NCT05419869: A trial that was reported late by Alto Neuroscience
This trial has reported, although it was 42 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05419869 |
|---|---|
| Title | An Open-Label Study of ALTO-100 in Adults With Major Depressive Disorder (MDD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 1, 2022 |
| Completion date | Jan. 13, 2023 |
| Required reporting date | Jan. 13, 2026, midnight |
| Actual reporting date | Feb. 24, 2026 |
| Date last checked at ClinicalTrials.gov | April 23, 2026 |
| Days late | 42 |